Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The objective of this study is to compare the efficacy and safety of aripiprazole as adjunctive therapy versus switching to different class of antidepressants for treating major depressive disorder partially or minimally responsive to ongoing antidepressant treatment.
Epistemonikos ID: 896ae6612bbf2f3986f9bf8c8fd748fd7fa52b94
First added on: May 10, 2024